// App-Quantinova.ai

BSH19‐PO‐005 : Using a Screening Technique to Identify New Combination Therapies with Potential to Improve Treatment of Paediatric Acute Myeloid Leukaemia

Researchers

Presenter

  • K. Lappin

Principal Investigators

  • L. Davis

  • K. Matchett

  • J. Blayney

  • K. Mills

Medical Centers

  • CCRCB, QUB, Belfast

  • NI Centre for Stratified Medicine, Ulster University, Derry/Londonderry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Acute Leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • C-X-C motif chemokine ligand 9

  • Fms related tyrosine kinase 3

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • Cysteine Hydrochloride

  • SU-9516

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved